
Web Accessibility Statement for AllisonsChemist.com
Commitment to Accessibility
Allisons Chemist is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website, which encompasses our online pharmacy and gift shop, and in doing so, adhere to many of the available standards and guidelines.
Conformance Status
We are committed to making our site conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA. These guidelines explain how to make web content more accessible for people with disabilities and are a globally recognized standard for digital accessibility.
Measures to Support Accessibility
AllisonsChemist.com takes the following measures to ensure accessibility:
-
Continuous Improvement: We integrate accessibility into our design and development process.
-
Regular Audits: We conduct regular internal and external audits to identify and fix accessibility issues.
-
Testing: We aim to test with a variety of users and assistive technologies to ensure a seamless experience.
Technical Specifications
​
Accessibility of AllisonsChemist.com relies on the following technologies to work with the particular combination of web browser and any assistive technologies or plugins installed on your computer:
-
HTML
-
CSS
-
JavaScript
These technologies are relied upon for conformance with the accessibility standards used.
Feedback and Contact Information
We welcome your feedback on the accessibility of AllisonsChemist.com. If you encounter any accessibility barriers while using our website, please let us know so we can promptly address them.
Contact Us:
-
E-mail: patientcare@allisonschemist.com
-
Phone: (01900) 822292
-
Postal Address: JWW Allison & Sons Ltd. 31 Main St. Cockermouth. CA13 9LE
We try to respond to feedback within 5 business days.
Formal Approval of this Accessibility Statement
This statement was approved by the management of Allisons Chemist on 22nd October 2025.
This statement was last updated on October 22, 2025.